Related Experiment Video
Updated: May 5, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Efavirenz dissolution enhancement I: co-micronization
Maíra Assis da Costa1, Rafael Cardoso Seiceira, Carlos Rangel Rodrigues
1Laboratory of Industrial Pharmaceutical Technology (LabTIF), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. cristianedrago@gmail.com.
Abstract:
AIDS constitutes one of the most serious infectious diseases, representing a major public health priority. Efavirenz (EFV), one of the most widely used drugs for this pathology, belongs to the Class II of the Biopharmaceutics Classification System for drugs with very poor water solubility. To improve EFV's dissolution profile, changes can be made to the physical properties of the drug that do not lead to any accompanying molecular modifications. Therefore, the study objective was to develop and characterize systems with efavirenz able to improve its dissolution, which were co-processed with sodium lauryl sulfate (SLS) and polyvinylpyrrolidone (PVP). The technique used was co-micronization. Three different drug:excipient ratios were tested for each of the two carriers. The drug dispersion dissolution results showed significant improvement for all the co-processed samples in comparison to non-processed material and corresponding physical mixtures. The dissolution profiles obtained for dispersion with co-micronized SLS samples proved superior to those of co-micronized PVP, with the proportion (1:0.25) proving the optimal mixture. The improvements may be explained by the hypothesis that formation of a hydrophilic layer on the surface of the micronized drug increases the wettability of the system formed, corroborated by characterization results indicating no loss of crystallinity and an absence of interaction at the molecular level.
Insights
This study improved efavirenz (EFV) dissolution using co-micronization with sodium lauryl sulfate (SLS) and polyvinylpyrrolidone (PVP). Co-processed EFV with SLS significantly enhanced drug dissolution compared to physical mixtures and PVP formulations.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Materials Science
Background:
- Acquired Immunodeficiency Syndrome (AIDS) is a major global health concern.
- Efavirenz (EFV), a key antiretroviral, exhibits poor water solubility (Biopharmaceutics Classification System Class II).
- Enhancing EFV dissolution is crucial for improving its therapeutic efficacy.
Purpose of the Study:
- To develop and characterize novel systems for efavirenz (EFV) with improved dissolution profiles.
- To investigate the efficacy of co-processing EFV with sodium lauryl sulfate (SLS) and polyvinylpyrrolidone (PVP) via co-micronization.
- To evaluate different drug:excipient ratios for optimal dissolution enhancement.
Main Methods:
- Co-micronization technique employed to process efavirenz (EFV) with sodium lauryl sulfate (SLS) and polyvinylpyrrolidone (PVP).
- Three distinct drug:excipient ratios were tested for each carrier.
- Dissolution profiles of co-processed samples were compared against non-processed EFV and physical mixtures.
Main Results:
- All co-processed EFV systems demonstrated significantly improved dissolution rates compared to untreated EFV and physical mixtures.
- Co-micronization with SLS yielded superior dissolution profiles over PVP.
- The optimal EFV:SLS ratio was identified as 1:0.25, showing the most substantial dissolution enhancement.
- Characterization confirmed no loss of crystallinity and no molecular interactions, suggesting improved wettability.
Conclusions:
- Co-micronization with SLS is an effective strategy to enhance the dissolution of poorly soluble efavirenz (EFV).
- The improved wettability of the co-processed drug, due to hydrophilic layer formation, is the likely mechanism for enhanced dissolution.
- This approach offers a promising method for improving the bioavailability of EFV without altering its molecular structure.
Related Concept Videos
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Factors Influencing Drug Absorption: Drug Dissolution
In Vitro Drug Dissolution: Alternative Methods
Bioavailability Enhancement: Drug Permeability Enhancement

